Subgroup Targeting
Cross-source consensus on Subgroup Targeting from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Benefits
Comparisons
Evidence quality
Highlighted claims
- Among females and people aged 65 or older, PAAP saved costs and generated more QALYs compared with usual care. — The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis
- PAAP was not uniformly cost-effective across all patient groups. — The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis
- The greatest PAAP benefits were observed among females, older adults, people with fewer comorbidities, and frequent antibiotic users. — The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis
- The article identifies males over 65 and females over 40 with recent antibiotic use as a promising targeting strategy. — The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis
- Lower apparent cost-effectiveness among patients with two or more QOF conditions may reflect a measurement artefact. — The cost-effectiveness of penicillin allergy assessment pathway (PAAP): a decision analysis